Pennsylvania's opioid habit is increasingly evident in the maternity ward, where it is causing problems for newborns and boosting costs, according to a report issued today by the Pennsylvania Health Care Cost Containment Council.

(Click image for larger version)
Babies born to mothers who used prescription opioids or heroin often suffer from neonatal abstinence syndrome and other problems.
From 2000 to 2015, the rate of neonatal hospital stays for substance problems increased by 250 percent, the state-funded council found. By last year, 19.5 out of every 1,000 newborns faced substance-related considerations, up from 5.6 per 1,000 in 2000.
Last year, neonatal abstinence syndrome was present in about 82 percent of newborns’ drug-related stays. The syndrome's prevalence increased almost ten-fold in that time.
“These findings stress the alarming impact that substance use problems have on new mothers and babies in communities across the Commonwealth,” said Joe Martin, the council's executive director, in a press release.
Last year, the council found, neonatal hospitalizations related to substance use added almost 28,000 hospitals days and an estimated $20.3 million in costs.
Low birth weight, respiratory distress and difficulty feeding were more than twice as likely in newborns with substance-related challenges. Prematurity was almost twice as likely.
The substance-related rate per 1,000 neonatal stays in 2015 was highest in Greene County, where more than one in 10 newborns faced a drug issue, and nearly as high in Fayette County. In Allegheny County, 20 out of every 1,000 neonatal stays involved a substance problem.
While maternal stays stemming from opioids increased six-fold over the 15-year period, those related to alcohol and cocaine dropped steeply.
Rich Lord: rlord@post-gazette.com or 412-263-1542. Twitter @richelord.
Here is the full report issued today by the Pennsylvania Health Care Cost Containment Council:
PHC4 Maternal Neonatal Substance Use Research Brief Final (PDF)
PHC4 Maternal Neonatal Substance Use Research Brief Final (Text)





Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.